title: Regulation of CREB expression: in vivo evidence for a functional role in morphine action in the nucleus accumbens.
abstract: Previous work has shown that chronic opiate administration regulates protein components of the cAMP signaling pathway, specifically in the nucleus accumbens (NAc), a brain region implicated in the reinforcing properties of opiates, and that such adaptations may contribute to changes in reinforcement mechanisms that characterize opiate addiction. In the present study, we examined a possible role for the transcription factor cAMP response element-binding protein (CREB) in mediating these long-term effects of opiates in the NAc. Chronic, but not acute, morphine administration was found to decrease levels of CREB immunoreactivity in the NAc, an effect not seen in other brain regions studied. The functional significance of this CREB down-regulation was then investigated by the use of an anti-sense oligonucleotide strategy that produces a specific and sustained decrease in CREB levels in the NAc, without detectable toxicity. It was found that the antisense oligonucleotide-induced reduction in CREB levels mimicked the effect of morphine on certain, but not all, cAMP pathway proteins in this brain region, whereas a large number of other signal transduction proteins tested were unaffected by this treatment. Our results support a role for CREB in autoregulation of the cAMP pathway in the nervous system, as well as in mediating some of the effects of morphine on this signaling pathway in the NAc.
authors.affiliation: Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.
authors.forename: K L
authors.initials: KL
authors.lastname: Widnell
authors.forename: D W
authors.initials: DW
authors.lastname: Self
authors.forename: S B
authors.initials: SB
authors.lastname: Lane
authors.forename: D S
authors.initials: DS
authors.lastname: Russell
authors.forename: V A
authors.initials: VA
authors.lastname: Vaidya
authors.forename: M J
authors.initials: MJ
authors.lastname: Miserendino
authors.forename: C S
authors.initials: CS
authors.lastname: Rubin
authors.forename: R S
authors.initials: RS
authors.lastname: Duman
authors.forename: E J
authors.initials: EJ
authors.lastname: Nestler
mesh_terms: D000818:Animals; D001483:Base Sequence; D017362:Cyclic AMP Response Element-Binding Protein / Q000235:genetics / Q000378:metabolism / Q000502:physiology*; D017868:Cyclic AMP-Dependent Protein Kinases / Q000276:immunology / Q000378:metabolism; D015536:Down-Regulation / Q000187:drug effects; D019204:GTP-Binding Proteins / Q000276:immunology / Q000378:metabolism; D008297:Male; D008969:Molecular Sequence Data; D009020:Morphine / Q000494:pharmacology*; D009714:Nucleus Accumbens / Q000187:drug effects* / Q000378:metabolism*; D016376:Oligonucleotides, Antisense / Q000494:pharmacology; D021382:Protein Sorting Signals / Q000378:metabolism / Q000502:physiology; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D012680:Sensitivity and Specificity; D015398:Signal Transduction / Q000187:drug effects / Q000502:physiology
chemical_list: D017362:Cyclic AMP Response Element-Binding Protein; D016376:Oligonucleotides, Antisense; D021382:Protein Sorting Signals; D012333:RNA, Messenger; D009020:Morphine; D017868:Cyclic AMP-Dependent Protein Kinases; D019204:GTP-Binding Proteins